Home / Health / Russia Trials Personalized Cancer Vaccine
Russia Trials Personalized Cancer Vaccine
1 Apr
Summary
- First personalized cancer vaccine administered on April 1.
- Patient received Neooncovac vaccine for skin melanoma.
- Vaccine "teaches" immune system to fight cancer cells.
On April 1, Russia marked a significant milestone in cancer treatment by administering the first Neooncovac personalized anti-cancer vaccine. This groundbreaking procedure took place at the National Medical Research Center for Radiology in Moscow.
The inaugural patient was a 60-year-old individual from the Kursk Region diagnosed with skin melanoma. This Neooncovac vaccine represents a new frontier in oncology, focusing on mRNA technology tailored to each patient.
According to Andrey Kaprin, the director general of the Radiology Center, this approach signifies a fundamental shift. It aims to personalize cancer treatment by instructing the patient's own immune system to precisely target and destroy harmful cells.
